Common examples of<unk> s or RADTs include: * COVID-19<unk> ing-related rapid<unk> s * Rapid strep<unk> s (for streptococcal<unk> s) * Rapid influenza diagnostic<unk> s (RIDTs) (for influenza virus<unk> s) * Malaria<unk>  detection<unk> s (for Plasmodium<unk> s) COVID-19<unk> s SARS-CoV-2 rapid<unk> s showing a negative and a positive result<unk> s for COVID-19 are one of the most useful application of these<unk> s. Often called lateral flow<unk> s, they have provided global governments with several benefits. They are quick to implement with minimal training, offered significant cost advantages, costing a fraction of existing forms of PCR<unk> ing and give users a result within 5–30 minutes.<unk> s have found their best use as part of mass<unk> ing or population-wide screening approaches. They are successful in these approaches because in addition to the aforementioned benefits, they identify individuals who are the most infectious and could potentially spread the virus to a large number of other people. This differs slightly from other forms of COVID-19<unk> s such as PCR that are generally seen to be a useful<unk>  for individuals. As early as February 2021, the US Department of State considered the<unk> <unk>  suitable for entry to the country. In Canada, although the<unk> <unk>  appeared to be no route to entry in January 2021, Health Canada in August 2021 made available subsidized at no cost<unk> s "to more small and medium-sized organizations through new pharmacy partners".
Rapid antigen test
Rapid diagnostic test
Rabbit test
Heterophile antibody test
Direct agglutination test
Rabbit Test
Widal test
Direct fluorescent antibody